Skip to main content

Table 3 Associations between triglyceride–glucose index and all-cause death and cardiovascular death

From: Association of triglyceride–glucose index with coronary severity and mortality in patients on dialysis with coronary artery disease

 

Model 4

Model 5

Model 6

HR

95% CI

P value

HR

95% CI

P value

HR

95% CI

P value

All-cause death

 TyG index

1.32

1.15–1.52

 < 0.001

1.34

1.17–1.54

 < 0.001

1.23

1.06–1.43

0.007

 Tertile 1

Reference

  

Reference

   

Reference

 

 Tertile 2

1.34

1.02–1.75

0.033

1.46

1.12–1.92

0.006

1.36

1.03–1.80

0.031

 Tertile 3

1.60

1.23–2.07

 < 0.001

1.61

1.24–2.08

 < 0.001

1.43

1.08–1.89

0.012

Cardiovascular death

 TyG index

1.40

1.18–1.65

 < 0.001

1.41

1.20–1.67

 < 0.001

1.33

1.11–1.59

0.002

 Tertile 1

Reference

  

Reference

   

Reference

 

 Tertile 2

1.41

1.02–1.95

0.040

1.53

1.01–2.12

0.011

1.52

1.08–2.14

0.016

 Tertile 3

1.73

1.26–2.37

 < 0.001

1.74

1.27–2.39

 < 0.001

1.68

1.20–2.36

0.002

  1. Model 4: unadjusted. Model 5: adjusted for age and sex. Model 6 for all-cause death: adjusted for age, sex, systolic blood pressure, diastolic blood pressure, heart rate, current smoker, atrial fibrillation, cerebrovascular disease, valvular disease, dialysis modality, cause of dialysis, insulin therapy, acute myocardial infarction as index presentation, left main disease, multivessel disease, moderate or severe calcification, Gensini score, angiotensin-converting enzyme inhibitor or angiotensin receptor blocker, and calcium-channel blocker. Model 6 for cardiovascular death: adjusted for age, sex, systolic blood pressure, diastolic blood pressure, diabetes mellitus, current smoker, atrial fibrillation, cause of dialysis, insulin therapy, acute myocardial infarction as index presentation, left main disease, multivessel disease, moderate or severe calcification, Gensini score, percutaneous coronary intervention treatment, angiotensin-converting enzyme inhibitor or angiotensin receptor blocker, and calcium-channel blocker
  2. CI confidence interval, HR hazard ratio, TyG triglyceride–glucose